Active Holistic Surveillance: The Nutritional Aspect of Delayed Intervention in Prostate Cancer.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27274870)

Published in J Nutr Metab on May 05, 2016

Authors

Courtney J Berg1, David J Habibian1, Aaron E Katz1, Kaitlin E Kosinski1, Anthony T Corcoran1, Andrew S Fontes1

Author Affiliations

1: Department of Urology, Winthrop University Hospital, Mineola, NY 11501, USA.

Articles cited by this

Cancer statistics, 2013. CA Cancer J Clin (2013) 84.72

Time trends and local variation in primary treatment of localized prostate cancer. J Clin Oncol (2010) 8.93

Active surveillance program for prostate cancer: an update of the Johns Hopkins experience. J Clin Oncol (2011) 5.27

Long-term follow-up of a large active surveillance cohort of patients with prostate cancer. J Clin Oncol (2014) 5.01

Active surveillance for the management of prostate cancer in a contemporary cohort. Cancer (2008) 4.77

Quality-of-life outcomes in men treated for localized prostate cancer. JAMA (1995) 4.69

Fat, meat, and prostate cancer. Epidemiol Rev (2001) 1.67

Effects of lycopene supplementation on oxidative stress and markers of endothelial function in healthy men. Atherosclerosis (2010) 1.61

Prostate cancer risk and consumption of fish oils: a dietary biomarker-based case-control study. Br J Cancer (1999) 1.58

International comparisons of mortality rates for cancer of the breast, ovary, prostate, and colon, and per capita food consumption. Cancer (1986) 1.51

Brassica vegetables and prostate cancer risk: a review of the epidemiological evidence. Nutr Cancer (2002) 1.46

Prostate cancer in Asian men. Nat Rev Urol (2014) 1.46

Green tea polyphenols for prostate cancer chemoprevention: a translational perspective. Phytomedicine (2010) 1.37

Nutrition and prostate cancer. Cancer Causes Control (1996) 1.20

Impact of diet on prostate cancer: a review. Prostate Cancer Prostatic Dis (2005) 1.12

Update on options for treatment of metastatic castration-resistant prostate cancer. Onco Targets Ther (2010) 1.00

Milk consumption is a risk factor for prostate cancer in Western countries: evidence from cohort studies. Asia Pac J Clin Nutr (2007) 0.99

A concentrated aglycone isoflavone preparation (GCP) that demonstrates potent anti-prostate cancer activity in vitro and in vivo. Clin Cancer Res (2004) 0.94

Omega-3 fatty acids and other FFA4 agonists inhibit growth factor signaling in human prostate cancer cells. J Pharmacol Exp Ther (2014) 0.91

Lycopene and 1,25-dihydroxyvitamin D3 cooperate in the inhibition of cell cycle progression and induction of differentiation in HL-60 leukemic cells. Nutr Cancer (1999) 0.89

Immunological effect of active hexose correlated compound (AHCC) in healthy volunteers: a double-blind, placebo-controlled trial. Nutr Cancer (2008) 0.87

Regression of prostate cancer following administration of Genistein Combined Polysaccharide (GCP), a nutritional supplement: a case report. J Altern Complement Med (2002) 0.87

Combination treatment of prostate cancer cell lines with bioactive soy isoflavones and perifosine causes increased growth arrest and/or apoptosis. Clin Cancer Res (2007) 0.87

Role of Vitamin D Metabolism and Activity on Carcinogenesis. Oncol Res (2015) 0.84

Zyflamend, a combination of herbal extracts, attenuates tumor growth in murine xenograft models of prostate cancer. Nutr Cancer (2012) 0.82

Combination therapy of active hexose correlated compound plus UFT significantly reduces the metastasis of rat mammary adenocarcinoma. Anticancer Drugs (1998) 0.82

Zyflamend inhibits the expression and function of androgen receptor and acts synergistically with bicalutimide to inhibit prostate cancer cell growth. Prostate (2011) 0.81

The inhibitory effect of genistein on the growth and metastasis of a transplantable rat accessory sex gland carcinoma. Cancer Lett (1999) 0.79

Diet and prostate cancer - a holistic approach to management. Arch Esp Urol (2011) 0.79

Dramatic prostate-specific antigen response with activated hemicellulose compound in metastatic castration-resistant prostate cancer. Anticancer Drugs (2009) 0.78

Suppressive effects of Active Hexose Correlated Compound on the increased activity of hepatic and renal ornithine decarboxylase induced by oxidative stress. Life Sci (2003) 0.77

Active Surveillance for Prostate Cancer: Debate over the Application, Not the Concept. Eur Urol (2015) 0.77

Vitamin D deficiency in the urological population: a single center analysis. J Urol (2011) 0.77